- Presentations
- 5
- Markets
- 1
Emflaza is a brand of Deflazacort marketed by PTC Therapeutics, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Deflazacort
- Brand owner
- PTC Therapeutics
- Registered in
- United States
- Strengths and forms
- 22.75 mg/mL oral suspension, 18 mg tablet, 30 mg tablet, 36 mg tablet, 6 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Emflaza 22.75 mg/mL oral suspensionOral | PTC Therapeutics | US FDA | Available on request |
| Emflaza 18 mg tabletOral | PTC Therapeutics | US FDA | Available on request |
| Emflaza 30 mg tabletOral | PTC Therapeutics | US FDA | Available on request |
| Emflaza 36 mg tabletOral | PTC Therapeutics | US FDA | Available on request |
| Emflaza 6 mg tabletOral | PTC Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Deflazacort.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Emflaza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.